Increased risk of tuberculosis after gastrectomy and chemotherapy in gastric cancer: A 7-year cohort study

Gastric Cancer

Volumn 14, Issue 3, 2011, Pages 257-265

  Huang, Shiang Fen ^a   Li, Chung Pin ^a,b   Feng, Jia Yih ^b   Chao, Yee ^a,b   Su, Wei Juin ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chemotherapy; Gastrectomy; Gastric cancer; Standardized incidence ratio; Tuberculosis

Indexed keywords

ANTINEOPLASTIC AGENT; TUBERCULOSTATIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GASTRECTOMY; GENDER; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH CANCER; TAIWAN; TUBERCULOSIS;

EID: 85027943856     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0037-1     Document Type: Article

References (34)

1. Nava-Aguilera E, Andersson N, Harris E, Mitchell S, Hamel C, Shea B, et al. Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13(1):17-26.
2. Zevallos M, Justman JE. Tuberculosis in the elderly. Clin Geriatr Med. 2003;19(1):121-38. (Pubitemid 36020198)
3. Corbett EL, Churchyard GJ, Clayton TC, Williams BG, Mulder D, Hayes RJ, et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS. 2000;14(17):2759-68. (Pubitemid 32118730)
4. Jackson A, Garber PE, Post GW. Coexistent pulmonary tuberculosis and malignancy. Dis Chest. 1957;32(2):189-97.
5. Kaplan MH, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer. 1974;33(3):850-8.
6. Feld R, Bodey GP, Groschel D. Mycobacteriosis in patients with malignant disease. Arch Intern Med. 1976;136(1):67-70.
7. Patel KC, Shah DP, Sheth SM, Kamat SR. Association of tuberculosis with malignancy. J Postgrad Med. 1977;23(4):193-6.
8. Ibrahim EM, Uwaydah A, al-Mulhim FA, Ibrahim AM, el-Hassan AY. Tuberculosis in patients with malignant disease. Indian J Cancer. 1989;26(2):53-7. (Pubitemid 19238282)
9. Libshitz HI, Pannu HK, Elting LS, Cooksley CD. Tuberculosis in cancer patients: an update. J Thorac Imaging. 1997;12(1):41-6. (Pubitemid 27065094)
10. De La Rosa GR, Jacobson KL, Rolston KV, Raad, II, Kontoyiannis DP, Safdar A. Mycobacterium tuberculosis at a comprehensive cancer centre: active diseaseinpatients with underlying malignancy during 1990-2000. Clin Microbiol Infect. 2004;10(8):749-52. (Pubitemid 39232691)
11. Stefan DC, Kruis AL, Schaaf HS, Wessels G. Tuberculosis in oncology patients. Ann Trop Paediatr. 2008;28(2):111-6.
12. Khan B, Ahmed P, Ullah K, Hussain CA, Hussain I, Raza S. Fre-quencyoftuberculosisin haematological malignancies and stem cell transplant recipients. J Coll Physicians Surg Pak. 2005;15(1):30-3. (Pubitemid 40347560)
13. Kim DK, Lee SW, Yoo CG, Kim YW, Han SK, Shim YS, et al. Clinical characteristics and treatment responses of tuberculosis in patients with malignancy receiving anticancer chemotherapy. Chest. 2005;128(4):2218-22. (Pubitemid 41507562)
14. Yokoyama T, Sato R, Rikimaru T, Hirai R, Aizawa H. Tuberculosis associated with gastrectomy. J Infect Chemother. 2004;10(5):299-302. (Pubitemid 40064213)
15. Boman K. Tuberculosis occurring after gastrectomy. Acta Chir Scand. 1956;110(6):451-7.
16. Thorn PA, Brookes VS, Waterhouse JA. Peptic ulcer, partial gas-trectomy, and pulmonary tuberculosis. Br Med J. 1956;1(4967): 603-8.
17. National Center for Health Statistics. Report of the workshop on age adjustment. Vital and Health Statistics. 1998;Series 4. No. 30.
18. Im JG, Itoh H, Shim YS, Lee JH, Ahn J. Pulmonary tuberculosis: CT findings-early active disease and sequential change with antituberculous therapy. Radiology. 1993;186:653-60. (Pubitemid 23073501)
19. Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li CP, Chou YJ. Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study. Int J Tuberc Lung Dis. 2011;15(1):1-6.
20. Tan KK, Cherian A, Teo SK. Tuberculosis in the elderly. Singapore Med J. 1991;32(6):423-6.
21. Kim HR, Hwang SS, Ro YK, Jeon CH, Ha DY, Park SJ, et al. Solid-organ malignancy as a risk factor for tuberculosis. Respi-rology. 2008;13(3):413-9. (Pubitemid 351503152)
22. Nair R, Prabhash K, Sengar M, Bakshi A, Gujral S, Gupta S, et al. The effect of short-term intensive chemotherapy on reactivation of tuberculosis. Ann Oncol. 2007;18(7):1243-5. (Pubitemid 47244372)
23. Latorre I, De Souza-Galvão M, Ruiz-Manzano J, Lacoma A, Prat C, Fuenzalida L, Altet N, Ausina V, Domínguez J. Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children. Diagn Microbiol Infect Dis. 2009;65:236-46.
24. Chee CB, Barkham TM, Khinmar KW, Gan SH, Wang YT. Quantitative T-cell interferon-gamma responses to Mycobacte-rium tuberculosis-specific antigens in active and latent tuberculosis. Eur J Clin Microbiol Infect Dis. 2009;28:667-70.
25. Janssens JP, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur Respir J. 2007;30:722-8.
26. Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007;175:618-27. (Pubitemid 46438947)
27. Goletti D, Vincenti D, Carrara S, Butera O, Bizzoni F, Bernardini G, Amicosante M, Girardi E. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol. 2005;12:1311-6. (Pubitemid 41626601)
28. Davidow AL. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis. Int J Tuberc Lung Dis. 2009;13:1411-5.
29. Chandra RK. Nutrition and immunity: lessons from the past and new insights into the future. Am J Clin Nutr. 1991;53(5): 1087-101.
30. Perronne C. Tuberculosis, HIV infection, and malnutrition: an infernal trio in central Africa. Nutrition. 1999;15(4):321-2.
31. Babcock A, editor. Nutrition and tuberculosis: a review of the literature and considerations for TB control programmes. Washington: US Agency for International Development; 2008.
32. Chandra RK. Nutritional deficiency and susceptibility to infection. Bull World Health Organ. 1979;57(2):167-77. (Pubitemid 9173524)
33. Karyadi E, Schultink W, Nelwan RH, Gross R, Amin Z, Dolmans WM, et al. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. J Nutr. 2000;130(12):2953-58. (Pubitemid 32005324)
34. Tsukamura M. In vitro susceptibility of mycobacteria, especially of Mycobacterium intracellulare, to 5-fluorouracil and pattern of development of resistance of Mycobacterium tuberculosis to the drug. Microbiol Immunol. 1979;23(5):427-9. (Pubitemid 9212198)